HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

Thoracic Neoplasms

Subscribe to New Research on Thoracic Neoplasms

Also Known As:

Neoplasm, Thoracic; Neoplasms, Thoracic; Thoracic Neoplasm

Networked: 27 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Neoplasms: 649836
- Neoplasms by Site: 1
  - Thoracic Neoplasms: 27

Related Diseases

1.	Neoplasms (Cancer)
2.	Pulmonary Fibrosis (Hamman Rich Syndrome)
3.	Neuroendocrine Tumors (Neuroendocrine Tumor)
4.	Radiation Pneumonitis (Radiation Fibrosis)
5.	Thymoma (Thymic Carcinoma)

Experts

1.	Karck, Matthias: 1 article (01/2015)
2.	Ruhparwar, Arjang: 1 article (01/2015)
3.	Dienemann, Hendrik: 1 article (01/2015)
4.	Eichhorn, Florian: 1 article (01/2015)
5.	Arif, Rawa: 1 article (01/2015)
6.	Seppelt, Philipp: 1 article (01/2015)
7.	Kallenbach, Klaus: 1 article (01/2015)
8.	Endo, Masahiro: 1 article (01/2014)
9.	Nakajima, Takashi: 1 article (01/2014)
10.	Yamamoto, Nobuyuki: 1 article (01/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Thoracic Neoplasms:

1.	Thymidine KinaseIBA 04/15/1994 - "Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system."
2.	Deoxyglucose (2 Deoxy D glucose)IBA 01/01/2012 - "The aim of this study is to examine the relationship between the expression level of excision repair cross-complementation group 1 (ERCC1) and of 2-[18F]-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET) in various thoracic neoplasm.Three" 01/01/2014 - "The aim of this study was to investigate the relationship between the expression levels of thymidylate synthase (TS) and 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (¹⁸F-FDG) uptake on positron emission tomography (PET) in various thoracic neoplasms. "
3.	Thymidylate SynthaseIBA 01/01/2014 - "¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms." 01/01/2014 - "The aim of this study was to investigate the relationship between the expression levels of thymidylate synthase (TS) and 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (¹⁸F-FDG) uptake on positron emission tomography (PET) in various thoracic neoplasms. "
4.	AsbestosIBA 04/01/1992 - "Asbestos exposures and thoracic neoplasms." 11/01/1998 - "In contrast, RCF1 and chrysotile asbestos induced pulmonary fibrosis and thoracic neoplasms (chrysotile induced 32% more pulmonary neoplasms than RCF1). "
5.	Thymic epithelial tumorIBA 01/01/2014 - "The expression of TS in thoracic neoplasms had a positivity of 58% (230/392), and the positive rates of TS expression in NSCLC, PMT, thymic epithelial tumor, NE tumor and MPM samples were 56, 57, 57, 85 and 47%, respectively. " 01/01/2012 - "The expression of ERCC1 in thoracic neoplasms had a positivity of 49% (152/308), and the positive rates of ERCC1 expression in NSCLC, PMT, thymic epithelial tumor, pulmonary neuroendocrine tumor and MPM were 52, 43, 53, 47 and 85%, respectively. "
6.	Sodium Selenite (Selenite)IBA 11/01/1972 - "[Scintigraphic tumor diagnostics using 75 Se sodium selenite in patients with malignant thoracic neoplasms]."
7.	Amosite Asbestos (Amosite)IBA 12/01/1993 - "If human beings are likely to react to amosite as do baboons, epidemiological follow-up should include identification of abdominal as well as thoracic neoplasms."
8.	Serpentine Asbestos (Chrysotile)IBA 11/01/1998 - "In contrast, RCF1 and chrysotile asbestos induced pulmonary fibrosis and thoracic neoplasms (chrysotile induced 32% more pulmonary neoplasms than RCF1). "
9.	Cadherins (E-Cadherin)IBA 01/01/1995 - "E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus." 01/01/1995 - "Reduced and disorganised expression of E-cadherin appear to be related to transcriptional and post-translational events respectively, and both appear to represent altered cell adhesion associated with invasion and metastasis in thoracic neoplasms."
10.	Talc FDA Link 10/01/2003 - "This could alter the diagnostic and therapeutic course for patients with a history of both thoracic neoplasm and talc pleurodesis."

Therapies and Procedures

1.	Aftercare (After-Treatment) 08/01/2005 - "The purpose of this study is to describe the CT appearance of thoracic neoplasms after treatment with radiofrequency ablation (RFA). "
2.	Radiotherapy 01/01/2012 - "It may thus play a promising role in facilitating clinical radiotherapy of thoracic neoplasms." 02/01/1983 - "Individualized radiotherapy planning can help exclude the breasts from treatment fields for some thoracic neoplasms." 01/01/1961 - "Radiotherapy in thoracic neoplasms." 01/01/2012 - "Radiation pneumonitis and pulmonary fibrosis are the main complications with radiotherapy for thoracic neoplasms, directly limiting the efficient dose in clinical application and currently there are few medicines that effectively function as radioprotectants. "
3.	Catheters 01/01/1999 - "Twenty-six patients with SVCO due to primary or secondary tumors of the lung or the mediastinum, or catheter inserted for treatment of an extra-thoracic neoplasm, had an endovascular therapy which consisted of stenting, angioplasty, thrombo-aspiration or local fibrinolysis. "
4.	Prostheses and Implants (Prosthesis) 11/01/2003 - "Radical resection combined with prosthesis replacement of SVC system extends the indications of thoracic neoplasm resection and improve the long-term survival rate and living qualities of the patients. "
5.	Pleurodesis 10/01/2003 - "This could alter the diagnostic and therapeutic course for patients with a history of both thoracic neoplasm and talc pleurodesis."